Breast cancer is the most commonly diagnosed cancer among American women — yet the gaps in care are wide.

A majority of women over age 40 skip the recommended annual screening.

Radiologists are reading more mammograms with fewer colleagues.

And when a diagnosis arrives, the tests that inform treatment can take weeks to return results.

Companies in the NVIDIA Inception program for startups are building AI applications to support clinicians at each of these friction points, including imaging, risk assessment and treatment planning.

About 40 million mammograms are performed in the U.S. each year, but a projected shortfall of tens of thousands of radiologists over the next decade is straining the system’s capacity to read them.

At the other end of the care timeline, treatment decisions often hinge on genomic assays sent off to outside labs — assays that take weeks to process, at a moment when speed and certainty matter most.

The companies below are addressing both ends of that gap, and everything in between, accelerated by NVIDIA AI infrastructure.

Automated Imaging Delivers AI-Powered Insights …